Drug Shortage Report for ZITHROMAX FOR INTRAVENOUS INJECTION

Last updated on 2020-10-05 History
Report ID 108753
Drug Identification Number 02239952
Brand name ZITHROMAX FOR INTRAVENOUS INJECTION
Common or Proper name ZITHROMAX FOR INJECTION
Company Name PFIZER CANADA ULC
Market Status MARKETED
Active Ingredient(s) AZITHROMYCIN
Strength(s) 500MG
Dosage form(s) POWDER FOR SOLUTION
Route of administration INTRAVENOUS
Packaging size 10 X 5mL vials
ATC code J01FA
ATC description MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2020-03-16
Estimated end date
Actual end date 2020-10-01
Shortage status Resolved
Updated date 2020-10-05
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 17300 TRANS-CANADA HIGHWAY
KIRKLAND, QUEBEC
CANADA H9J 2M5
Company contact information Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2020-03-16 English Compare
v2 2020-03-16 English Compare
v3 2020-03-16 French Compare
v4 2020-03-17 English Compare
v5 2020-05-04 English Compare
v6 2020-05-04 French Compare
v7 2020-05-04 English Compare
v8 2020-05-04 French Compare
v9 2020-09-09 English Compare
v10 2020-09-09 French Compare
v11 2020-10-05 English Compare
v12 2020-10-05 French Compare

Showing 1 to 12 of 12